Phase I trial of the anti-idiotypic monoclonal antibody (mAb) ACA-125 in patients with epithelial ovarian, fallopian tube or primary peritoneal cancer This is an ASCO Meeting Abstract from the 2004 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results